DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CFO Blake Jeffrey Grayson sold 16,111 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total value of $1,340,435.20. Following the sale, the chief financial officer now owns 93,960 shares of the company’s stock, valued at $7,817,472. This trade represents a 14.64 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Blake Jeffrey Grayson also recently made the following trade(s):
- On Friday, February 14th, Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock. The stock was sold at an average price of $86.90, for a total value of $695,200.00.
DocuSign Price Performance
DOCU opened at $88.06 on Friday. The company has a market capitalization of $17.79 billion, a PE ratio of 18.16, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The business has a 50-day moving average of $87.54 and a 200-day moving average of $80.15.
Institutional Investors Weigh In On DocuSign
Large investors have recently bought and sold shares of the business. Toronto Dominion Bank lifted its position in shares of DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after buying an additional 6,081 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of DocuSign by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after acquiring an additional 16,014 shares in the last quarter. Quantinno Capital Management LP lifted its holdings in DocuSign by 39.5% in the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after purchasing an additional 57,104 shares during the last quarter. Rhumbline Advisers boosted its position in DocuSign by 118.8% during the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock worth $54,695,000 after purchasing an additional 330,136 shares during the period. Finally, KBC Group NV grew its holdings in DocuSign by 32.7% during the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock valued at $138,067,000 after purchasing an additional 378,233 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
DOCU has been the topic of a number of analyst reports. William Blair raised DocuSign from a “market perform” rating to an “outperform” rating in a research note on Monday, March 17th. Wells Fargo & Company boosted their price target on shares of DocuSign from $70.00 to $73.00 and gave the company an “underweight” rating in a report on Friday, March 14th. Robert W. Baird set a $93.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Bank of America reduced their target price on DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a report on Friday, March 14th. Finally, JPMorgan Chase & Co. upgraded DocuSign from an “underweight” rating to a “neutral” rating and lifted their price target for the company from $70.00 to $75.00 in a report on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, DocuSign has a consensus rating of “Hold” and a consensus price target of $95.00.
View Our Latest Research Report on DOCU
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Market Cap Calculator: How to Calculate Market Cap
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 3 Fintech Stocks With Good 2021 Prospects
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.